A

ATAI Life Sciences NV
D

ATAI

3.92000
USD
0.17
(4.53%)
مفتوح الان
حجم التداول
55,784
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
1,423,706,846
الأخبار المقالات

العنوان: Atai Beckley NV

القطاع: Healthcare
الصناعة: Biotechnology
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.